Rue François-Bellot 6
3 articles about MaxiVAX SA
Biopharma and life sciences companies from across the globe provide updates on their business and pipelines.
MaxiVAX awarded €2,785,000 European Commission grant and announces successful closing of its Series B 2 round for an amount of CHF 5 million
MaxiVAX wins grant among 94 projects funded out of 2,015 applications
MaxiVAX SA Release: Swiss Biotech Starts Breakthrough Anti-Cancer Clinical Trial Based On Active Immunotherapy